UNSPSC 51286205: Fosfomycin sodium

This classification denotes a urinary anti-infective agent with the molecular formula C3H5O4P.2Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 97MMO19FNO, chemically known as phosphonic acid, (3-methyloxiranyl)-, disodium salt, (2r-cis)- but more generally known as fosfomycin sodium, which bears US NIH Compound Identifier 3417. European Medicines Agency schedules Fosfomycin sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02262MIG. Most nations schedule fosfomycin sodium under HS 29419000.

As of Q4 2014, FOSFOMYCIN SODIUM remains the US FDA Preferred Term for this commodity. SMILES: C[C@H]1[C@H](O1)P(=O)([O-])[O-].[NA+].[NA+].

UNSPSC 51286205 Fosfomycin sodium is a Commodity code that in recent state and local procurement shows minimal alignment with its nominal pharmaceutical scope. The code appears in the state and local opportunity database tagged to procurements that encompass emergency medical supplies, naloxone and drug deactivation systems, multi-source generic pharmaceuticals, and OTC products — a broad health-sector purchasing pattern rather than fosfomycin-specific demand. Issuing bodies span state health agencies (Texas Health and Human Services Commission, Minnesota Department of Administration), county governments (Seminole County, Florida), and city fire and rescue departments (Tampa Fire Department), reflecting distributed public-health and emergency-response procurement across different jurisdictional tiers. The actual work being solicited under this code tag includes emergency response consumables, pharmaceutical supply agreements through cooperative purchasing vehicles, and first-aid supplies for municipal rescue operations.

Recent activity shows geographic concentration in Florida and Texas, with Minnesota activity driven by the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) serving multi-state participation. Representative opportunities include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually (IFB 60459723LAS, due July 26, 2023); the City of Tampa's ITB for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, estimated at $700,000, with a 5 percent bid discount for certified Small Local Business Enterprises (ITB 26P00145, due March 13, 2026); the Texas Health and Human Services Commission's Request for Information on direct-to-manufacturer prescriptions (RFI HHS0017013, due April 3, 2026); and MMCAP's RFP for generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers, with proposals due March 26, 2026. The code shows limited recent activity specifically tied to fosfomycin procurement, suggesting either narrow demand or systematic tagging misalignment between the code's pharmaceutical classification and how state and local agencies structure health-sector solicitations.